Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-translational modifications: Regulators of neurodegenerative proteinopathies
Rohan Gupta, Mehar Sahu, Devesh Srivastava, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101336-101336
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
Protein lipidation in health and disease: molecular basis, physiological function and pathological implication
Yuan Yuan, Peiyuan Li, Jianghui Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT
Mengdie Dong, Yunjia Zhang, Minghong Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3027-3048
Open Access | Times Cited: 16
Protein S-sulfhydration: Unraveling the prospective of hydrogen sulfide in the brain, vasculature and neurological manifestations
Rohan Gupta, Mehar Sahu, Rahul Tripathi, et al.
Ageing Research Reviews (2022) Vol. 76, pp. 101579-101579
Closed Access | Times Cited: 39
The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations
Nicholas Aderinto, Gbolahan Olatunji, Muili Abdulbasit, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e35557-e35557
Open Access | Times Cited: 25
Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration
Saima Zafar, Shehzadi Irum Fatima, Matthias Schmitz, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 118-118
Open Access | Times Cited: 12
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 10
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Role of SUMOylation in Neurodegenerative Diseases
Nicolas Mandel, Nitin Agarwal
Cells (2022) Vol. 11, Iss. 21, pp. 3395-3395
Open Access | Times Cited: 30
Deepro-Glu: combination of convolutional neural network and Bi-LSTM models using ProtBert and handcrafted features to identify lysine glutarylation sites
Xiao Wang, Zhaoyuan Ding, Rong Wang, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 18
Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer
Aastha Kaushik, Somya Parashar, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102279-102279
Closed Access | Times Cited: 8
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
Rita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1279-1279
Open Access | Times Cited: 26
Lactylation may be a Novel Posttranslational Modification in Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy
Yue Zhou, Li Yang, Xiaoying Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Proteomic characterization of post-translational modifications in drug discovery
Linhui Zhai, Kai‐Feng Chen, Bingbing Hao, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3112-3129
Open Access | Times Cited: 23
UCP1 alleviates renal interstitial fibrosis progression through oxidative stress pathway mediated by SIRT3 protein stability
Wei Xiong, Zhiyong Xiong, Anni Song, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Role of succinylation modification in central nervous system diseases
Chao Wang, Weigang Cui, Bing Yu, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102242-102242
Closed Access | Times Cited: 5
PAD2: A potential target for tumor therapy
Yi Teng, Yuhang Chen, Xinyi Tang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188931-188931
Closed Access | Times Cited: 12
Post-translational modifications and immune responses in liver cancer
Youwei Wang, Jiachen Zuo, Chong Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Gut dysbiosis and neurological modalities: An engineering approach via proteomic analysis of gut-brain axis
Meenakshi Kandpal, Nidhi Varshney, Kunal Sameer Rawal, et al.
Advances in protein chemistry and structural biology (2024), pp. 199-248
Closed Access | Times Cited: 4
UFMylation: An integral post-translational modification for the regulation of proteostasis and cellular functions
Xiaohui Wang, Xiaowei Lv, Jingjing Ma, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108680-108680
Closed Access | Times Cited: 4
Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K / AKT Pathway in Parkinson’s Disease
Benchi Cai, Qitong Wang, Lifan Zhong, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2869-2881
Open Access | Times Cited: 4
Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease
Nandita Ravichandran, Mahalaxmi Iyer, Deenathayalan Uvarajan, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments
Clara Bosbach, Luisa Maria Gatzemeier, Katja Ilme Bloch von Blottnitz, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 13, pp. 2670-2676
Open Access | Times Cited: 3
Proteomic insights uncover enhanced neurotherapeutic potential in conditioned mesenchymal stem cell-derived extracellular vesicles
Junxiu Xi, Tian Wang, Panpan Xian, et al.
Extracellular Vesicle (2024) Vol. 3, pp. 100037-100037
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top